Clinical Trial Update: A Study of AB-218 in Patients With IDH1 Mutated Low Grade Glioma [EARLY_Phase 1]

View source ↗

Summary

This update reports the completion of an early-phase study of AB-218 in IDH1-mutated low-grade glioma, with the trial status now listed as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Glioma

Drugs mentioned

• AB-218

Snippet

Sponsor: Melbourne Health | Conditions: Glioma | EARLY_Phase 1 | Status: COMPLETED